Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Patrick K. Reville"'
Autor:
Elisabeth Paietta, Fangxin Hong, Brad S. Kahl, Kyung Mann Kim, Vaishalee P. Kenkre, Bartosz Grzywacz, Erik A. Ranheim, Patrick K. Reville, Lakeesha Carmichael, Eneida A. Mendonça, Amy K. Erbe, Wei Wang, Paul M. Sondel, Sandra J. Horning, Anna Hoefges, Yiqiang Song, Songwon Seo, Jeffrey S. Miller, Randy D. Gascoyne, Jacquelyn A. Hank
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Background The ECOG-ACRIN Cancer Research Group evaluated rituximab treatment schedules for patients with newly-diagnosed low-tumor-burden follicular-lymphoma (FL). All patients received 4-weekly rituximab treatments as induction therapy. Clinically-
Autor:
Amy K. Erbe, Wei Wang, Patrick K. Reville, Lakeesha Carmichael, KyungMann Kim, Eneida A. Mendonca, Yiqiang Song, Jacquelyn A. Hank, Wendy B. London, Arlene Naranjo, Fangxin Hong, Michael D. Hogarty, John M. Maris, Julie R. Park, M. F. Ozkaynak, Jeffrey S. Miller, Andrew L. Gilman, Brad Kahl, Alice L. Yu, Paul M. Sondel
Publikováno v:
Frontiers in Immunology
Frontiers in immunology, vol 8, iss JUN
Frontiers in Immunology, Vol 8 (2017)
Frontiers in immunology, vol 8, iss JUN
Frontiers in Immunology, Vol 8 (2017)
Killer-cell immunoglobulin-like receptors (KIRs) are a family of glycoproteins expressed primarily on natural killer cells that can regulate their function. Inhibitory KIRs recognize MHC class I molecules (KIR-ligands) as ligands. We have reported as